Etodolac and Zanaflex drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Etodolac (etodolac) and Zanaflex (tizanidine hydrochloride). Common drug interactions include gait disturbance among females and neck pain among males.

The phase IV clinical study analyzes what interactions people have when they take Etodolac and Zanaflex. It is created by eHealthMe based on reports of 93 people who take the same drugs from the FDA, and is updated regularly.

What is Etodolac?

Etodolac has active ingredients of etodolac. It is often used in arthritis. eHealthMe is studying from 9,157 Etodolac users. Check the latest studies of Etodolac.

What is Zanaflex?

Zanaflex has active ingredients of tizanidine hydrochloride. It is often used in muscle spasms. eHealthMe is studying from 17,476 Zanaflex users. Check the latest studies of Zanaflex.



On Jul, 19, 2026

93 people who take Etodolac and Zanaflex together, and have interactions are studied.

Etodolac and Zanaflex drug interactions.

What are the common drug interactions of Etodolac and Zanaflex, by gender? *:

female:

  1. Gait disturbance
  2. Cough
  3. Dizziness
  4. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  5. Rash
  6. Asthma
  7. Ataxia (loss of full control of bodily movements)
  8. Balance disorder
  9. Chronic sinusitis (long lasting inflammation of the paranasal sinuses)
  10. Confusional state

male:

  1. Neck pain
  2. Arthralgia (joint pain)
  3. Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs)
  4. Erythema (redness of the skin)
  5. Foramen magnum stenosis (opening is not large enough for the spinal cord to easily pass)
  6. Gait disturbance
  7. Gingival bleeding (bleeding gums)
  8. Hypoaesthesia (reduced sense of touch or sensation)
  9. Hypoxia (low oxygen in tissues)
  10. Impaired healing

What are the common drug interactions of Etodolac and Zanaflex, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Neck pain
  2. Back pain
  3. Arthralgia (joint pain)
  4. Atelectasis (partial or complete collapse of the lung)
  5. Back disorder
  6. Bone disorder
  7. Cardiovascular disorder (heart diseases)
  8. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  9. Dry mouth
  10. Dyspepsia (indigestion)

40-49:

  1. Arthralgia (joint pain)
  2. Colitis (inflammation of colon)
  3. Disturbance in attention
  4. Gait disturbance
  5. Hypoaesthesia (reduced sense of touch or sensation)
  6. Joint range of motion decreased (disease of joint movement)
  7. Knee arthroplasty
  8. Memory impairment
  9. Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  10. Peroneal nerve palsy

50-59:

  1. Pain in extremity
  2. Rash pruritic (redness with itching)
  3. Swelling face
  4. Vision blurred
  5. Abnormal dreams
  6. Blood pressure fluctuation
  7. Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
  8. Cough
  9. Depression
  10. Diarrhoea

60+:

  1. Asthenia (weakness)
  2. Dysphonia (speech disorder attributable to a disorder of phonation)
  3. Confusional state
  4. Cough
  5. Depression
  6. Diplopia (double vision)
  7. Dizziness
  8. Dry mouth
  9. Dry skin
  10. Dysstasia (difficulty in standing)

What are the existing conditions these people have? *

  1. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 28 people, 30.11%
  2. Pain: 27 people, 29.03%
  3. Gait Disturbance: 21 people, 22.58%
  4. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 16 people, 17.20%
  5. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 15 people, 16.13%
  6. Osteoporosis (bones weak and more likely to break): 14 people, 15.05%
  7. Cough: 14 people, 15.05%
  8. Urethritis Noninfective (inflammation of the urethra - non infective): 13 people, 13.98%
  9. Blood Glucose Abnormal: 12 people, 12.90%
  10. Bladder Disorder: 11 people, 11.83%

* Approximation only. Some reports may have incomplete information.

Do you take Etodolac and Zanaflex?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Etodolac and Zanaflex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Etodolac:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Zanaflex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Etodolac and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zanaflex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on etodolac and tizanidine hydrochloride (the active ingredients of Etodolac and Zanaflex, respectively), and Etodolac and Zanaflex (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: